Statistics for Arcutis Biotherapeutics (id:7845 ARQT)

Valuation metrics

Market cap

1.35B

Enterprise value

1.14B

Trailing P/E (ttm)

-3.04

Forward P/E

-11.74

PEG ratio

-11.74

Price/Sales (ttm)

9.71

Price/Book (mrq)

8.60

Enterprise Value/Revenue

8.21

Enterprise Value/EBITDA

-6.34

Overview

Shares outstanding

117.04M

Float

85.83M

Shares short

27.76M

% Held by insiders

0.02%

% Held by institutions

1.13%

Average volume (10 days)

2.20M

Average volume (90 days)

Price summary

52-Week low

1.76

52-Week high

13.17

52-Week change

83.49%

Beta

1.18

50-Day moving average

9.57

200-Day moving average

9.54

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-140.97%

Operating margin

-87.29%

Operational effectiveness

Return on assets

-31.14%

Return on equity

-192.31%

Income statement

Revenue (ttm)

1.23

Revenue per share (ttm)

1.23

Quarterly revenue growth (yoy)

Gross profit (ttm)

54.62M

EBITDA

-179,408,000.00

Net income to common (ttm)

-195,535,008.00

Diluted EPS (ttm)

-1.67

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

330.56M

Total cash per share (mrq)

2.82

Total debt (mrq)

208.18M

Total Debt/Equity (mrq)

132.90

Current ratio (mrq)

245.70%

Book value per share (mrq)

1.34

Cash flow

Cash flow statement

-167,654,000.00

Levered free cash flow (LFCF)

-96,382,624.00